Novavax Inc (NVAX)

Total Costs & Expenses

$641.13M

TTM · Period ending: · USD

NVAX logo

NVAX Total Costs & Expenses

Latest reported$641.13M
NVAX TTM Total Costs & Expenses ($5.50M → $641.13M)
High-resolution chart · PNG

NVAX total costs & expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Novavax Inc Total Costs & Expenses — Trailing twelve months (TTM) (USD)
Period endingTotal Costs & Expenses (USD)
641,130,000
663,096,000
659,294,000
752,566,000
722,633,000
843,549,000
924,993,000
1,180,512,000
1,109,678,000
1,224,161,000
1,297,915,000
1,354,710,000
2,068,780,000
2,368,696,000
2,457,734,000
2,024,491,000
1,648,713,000
1,623,674,000
1,884,157,000
2,248,207,000
2,113,185,000
1,521,904,000
892,317,000
467,326,000
142,870,000
130,328,000
148,259,000
163,377,000
186,502,000
199,245,000
208,206,000
213,764,000
214,109,000
209,546,000
202,886,000
204,133,000
220,692,000
251,492,000
284,466,000
309,777,000
282,962,000
238,776,000
193,486,000
147,119,000
135,398,000
126,691,000
114,348,000
98,961,000
91,039,000
81,358,000
73,349,000
64,409,000
56,942,000
53,471,000
51,742,000
47,785,000
44,147,000
40,111,000
36,266,000
33,245,000
34,983,000
35,536,000
38,836,000
45,981,000
43,730,000
42,114,000
37,708,000
32,760,000
34,217,000
34,904,000
35,424,000
28,811,000
29,463,000
29,800,000
31,782,000
37,303,000
33,618,000
32,612,000
29,290,000
16,638,000
13,855,000
13,518,000
16,559,000
32,977,000
31,846,000
34,651,000
33,388,000
28,542,000
32,798,000
29,360,000
27,839,000
27,322,000
28,899,000
31,971,000
36,564,000
39,138,000
37,742,000
37,390,000
33,321,000
30,047,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.